Eli Lilly introduced a generic version of Humalog at half the price, called insulin lispro, in March 2019. But this effort to make insulin more affordable may not be having that much of an impact for many people with diabetes, a data analysis shows. One reason is that the cheaper version isn’t actually cheaper, or even an option, with some people’s insurance. Read more